Point72 Asia (Singapore)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-185
Closed -$144K 1099
2025
Q2
$144K Buy
+185
New +$144K 0.03% 408
2025
Q1
Sell
-1,813
Closed -$1.4M 1065
2024
Q4
$1.4M Sell
1,813
-19,739
-92% -$16.3M 0.37% 73
2024
Q3
$19.1M Buy
+21,552
New +$19.4M 3.59% 6

Other funds holding LLY

Point72 Asia (Singapore)'s LLY Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 185 shares — an estimated $144K sold.

Point72 Asia (Singapore) first reported a position in LLY in Q3 2024 and held it in 3 quarters. The position peaked at $19.1M in Q3 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Point72 Asia (Singapore) reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 185 Eli Lilly shares in Q3 2025, an estimated $144K.
  • Point72 Asia (Singapore) first reported a position in Eli Lilly in Q3 2024 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s Eli Lilly position peaked at $19.1M in Q3 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.